BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bittaye M, Cash P. Streptococcus pneumoniae proteomics: determinants of pathogenesis and vaccine development. Expert Rev Proteomics 2015;12:607-21. [PMID: 26524107 DOI: 10.1586/14789450.2015.1108844] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Sharapova YA, Švedas VK. Molecular Modeling of the Binding of the Allosteric Inhibitor Optactin at a New Binding Site in Neuraminidase A from Streptococcus pneumoniae. Moscow Univ Chem Bull 2018;73:205-11. [DOI: 10.3103/s0027131418050097] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Xu D, Wu X, Peng L, Chen T, Huang Q, Wang Y, Ye C, Peng Y, Hu D, Fang R. The Critical Role of NLRP6 Inflammasome in Streptococcus pneumoniae Infection In Vitro and In Vivo. Int J Mol Sci 2021;22:3876. [PMID: 33918100 DOI: 10.3390/ijms22083876] [Reference Citation Analysis]
3 Wang G, Zhao G, Chao X, Xie L, Wang H. The Characteristic of Virulence, Biofilm and Antibiotic Resistance of Klebsiella pneumoniae. Int J Environ Res Public Health 2020;17:E6278. [PMID: 32872324 DOI: 10.3390/ijerph17176278] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
4 Bidmos FA, Siris S, Gladstone CA, Langford PR. Bacterial Vaccine Antigen Discovery in the Reverse Vaccinology 2.0 Era: Progress and Challenges. Front Immunol 2018;9:2315. [PMID: 30349542 DOI: 10.3389/fimmu.2018.02315] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
5 Moens L, Hermand P, Wellens T, Wuyts G, Derua R, Waelkens E, Ysebaert C, Godfroid F, Bossuyt X. Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization. Hum Vaccin Immunother 2018;14:1234-42. [PMID: 29400602 DOI: 10.1080/21645515.2018.1430541] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Sharapova Y, Švedas V, Suplatov D. Catalytic and lectin domains in neuraminidase A from Streptococcus pneumoniae are capable of an intermolecular assembly: Implications for biofilm formation. FEBS J 2021;288:3217-30. [PMID: 33108702 DOI: 10.1111/febs.15610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Sharapova Y, Suplatov D, Švedas V. Neuraminidase A from Streptococcus pneumoniae has a modular organization of catalytic and lectin domains separated by a flexible linker. FEBS J 2018;285:2428-45. [PMID: 29704878 DOI: 10.1111/febs.14486] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
8 Bittaye M, Cash P, Forbes K. Proteomic variation and diversity in clinical Streptococcus pneumoniae isolates from invasive and non-invasive sites. PLoS One 2017;12:e0179075. [PMID: 28575057 DOI: 10.1371/journal.pone.0179075] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
9 Tao J, Hossain MZ, Xu Z, Ho HC, Khan MA, Huang C, Zheng H, Ni J, Fan Y, Bogale D, Su H, Cheng J. Protective effect of pneumococcal conjugate vaccination on the short-term association between low temperatures and childhood pneumonia hospitalizations: Interrupted time-series and case-crossover analyses in Matlab, Bangladesh. Environ Res 2022;212:113156. [PMID: 35331698 DOI: 10.1016/j.envres.2022.113156] [Reference Citation Analysis]
10 Cavallari M, De Libero G. From Immunologically Archaic to Neoteric Glycovaccines. Vaccines (Basel) 2017;5:E4. [PMID: 28134792 DOI: 10.3390/vaccines5010004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
11 Robbins A, Bahuaud M, Hentzien M, Maestraggi Q, Barbe C, Giusti D, Le Naour R, Batteux F, Servettaz A. The 13-Valent Pneumococcal Conjugate Vaccine Elicits Serological Response and Lasting Protection in Selected Patients With Primary Humoral Immunodeficiency. Front Immunol 2021;12:697128. [PMID: 34290713 DOI: 10.3389/fimmu.2021.697128] [Reference Citation Analysis]